Table 3.

Leucocyte counts at different time points

Time	Total leucocyte count		Neutrophil count		Monocytes count
	(109 l−1)		(109 l−1)		(109 l−1)
	Control group	Parecoxib group	Control group	Parecoxib group	Control group	Parecoxib group
T1	6.3 ± 1.0	6.3 ± 0.8	2.6 ± 0.6	2.5 ± 0.5	0.3 ± 0.12	0.4 ± 0.11
T2	12.9 ± 1.9	8.9 ± 2.1*	9.5 ± 1.6	7.0 ± 1.7*	0.7 ± 0.11	0.6 ± 0.11
T3	14.8 ± 2.3	11.9 ± 1.4*	11.6 ± 2.3	9.1 ± 1.5*	0.8 ± 0.13	0.9 ± 0.20
T4	16.7 ± 2.4	14.2 ± 1.9*	13.9 ± 3.0	11.8 ± 2.9*	1.0 ± 0.15	1.2 ± 0.21
T5	21.2 ± 3.8	18.6 ± 2.9*	16.3 ± 2.2	14.6 ± 3.0*	1.2 ± 0.16	1.3 ± 0.31
T6	14.0 ± 3.7	14.9 ± 3.2	10.8 ± 2.8	11.0 ± 2.4	1.4 ± 0.25	1.3 ± 0.28

Data are shown by means ± SD, *P < 0.05 vs. control group. Timepoints: T1, before start of CPB; T2, at the end of CPB; T3, 2 h after the CPB; T4,12 h after the CPB; T5, 24 h after the CPB; T6, 48 h after the CPB.